Inventor · disambiguated record
Munir A. Hussain
Also filed as: HUSSAIN MUNIR · HUSSAIN MUNIR A · HUSSAIN MUNIR ALWAN
15 granted patents·8 pending applications·542 citations·filing 1985–2018
94Inventor score
Files withBRISTOL MYERS SQUIBB CO3BRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC3DU PONT3DU PONT PHARM CO3DU PONT MERCK PHARMA2
Top patents by PatentIndex Score
23 records- 0193US4673679AUse of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administrationDU PONT·Filed 1986·Granted Jun 16, 1987·173 cites·8 claims
- 0290US6214834B1Integrin inhibitor prodrugsDU PONT PHARM CO·Filed 1998·Granted Apr 10, 2001·57 cites·42 claims
- 0389US8598185B2Unitary pharmaceutical dosage formDAHL TERRENCE C·Filed 2006·Granted Dec 3, 2013·12 cites·14 claims
- 0487US9018192B2Unitary pharmaceutical dosage formBRISTOL MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2013·Granted Apr 28, 2015·10 cites·2 claims
- 0587US5961483AIontophoretic delivery of cell adhesion inhibitorsFiled 1997·Granted Oct 5, 1999·83 cites·26 claims
- 0686US9545414B2Unitary pharmaceutical dosage formBRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2015·Granted Jan 17, 2017·6 cites·19 claims
- 0786US5849736AIsoxazoline and isoxazole fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 15, 1998·70 cites·31 claims
- 0879US6649187B2Use of polyalkylamine polymers in controlled release devicesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 18, 2003·9 cites·29 claims
- 0976US6185453B1Iontophoretic delivery of integrin inhibitorsDU PONT PHARM CO·Filed 1997·Granted Feb 6, 2001·52 cites·11 claims
- 1071US6114328AIsoxazoline and isoxazole fibrogen receptor antagonistsDU PONT PHARM CO·Filed 1997·Granted Sep 5, 2000·27 cites·49 claims
- 1169US2015080399A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECTBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1268US2019125875A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED Ph EFFECTBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1364US2018021436A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED Ph EFFECTBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1461US5704297ADry powder composition of hydroxyethyl starch suitable for reconstitutionDU PONT MERCK PHARMA·Filed 1991·Granted Jan 6, 1998·18 cites·6 claims
- 1558US2013203759A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECTNIKFAR FARANAK·Filed 2011·Application pending·0 cites
- 1658US2006057196A1Efavirenz tablet formulation having unique biopharmaceutical characteristicsHUSSAIN MUNIR A·Filed 2005·Application pending·0 cites
- 1755US2003124186A1Efavirenz tablet formulation having unique biopharmaceutical characteristicsFiled 2002·Application pending·0 cites
- 1853US2017079999A1Unitary pharmaceutical dosage formBRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2016·Application pending·0 cites
- 1951US2005059719A1Solid dosage formulation containing a Factor Xa inhibitor and methodFiled 2004·Application pending·0 cites
- 2045US6095326APackaging of disposable gloves with consumer tissue productsFiled 1999·Granted Aug 1, 2000·19 cites·2 claims
- 2143US4965066AIntranasal administration of 3,3-disubstituted indolinesDU PONT·Filed 1989·Granted Oct 23, 1990·3 cites·25 claims
- 2239US4757062ASubstituted benzoate ester prodrugs of estrogensDU PONT·Filed 1985·Granted Jul 12, 1988·3 cites·32 claims
- 2323USD840707SCrib with inlaid-stone headboardM DESIGN VILLAGE LLC·Filed 2017·Granted Feb 19, 2019·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Munir A. Hussain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →